XLV Holdings Information

XLV is an equity ETF with a total of 63 individual holdings. The top holdings are Eli Lilly and Company stock at 16.36%, Johnson & Johnson at 10.19%, AbbVie at 7.08%, UnitedHealth Group at 6.35%, and Merck & Co. at 5.45%.

Total Holdings

Top 10 Percentage

60.70%

Asset Class

Equity

ETF Category

Health

Assets

38.25B

PE Ratio

22.39

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	16.36%	5,615,941
2	JNJ	Johnson & Johnson	10.19%	17,079,088
3	ABBV	AbbVie Inc.	7.08%	12,525,568
4	UNH	UnitedHealth Group Incorporated	6.35%	6,419,754
5	MRK	Merck & Co., Inc.	5.45%	17,590,264
6	TMO	Thermo Fisher Scientific Inc.	3.35%	2,662,690
7	AMGN	Amgen Inc.	3.32%	3,816,229
8	GILD	Gilead Sciences, Inc.	3.10%	8,792,835
9	ISRG	Intuitive Surgical, Inc.	2.76%	2,516,818
10	ABT	Abbott Laboratories	2.75%	12,323,546
11	PFE	Pfizer Inc.	2.72%	40,294,997
12	CVS	CVS Health Corporation	2.17%	9,016,268
13	BMY	Bristol-Myers Squibb Company	2.12%	14,432,647
14	VRTX	Vertex Pharmaceuticals Incorporated	2.08%	1,800,101
15	DHR	Danaher Corporation	2.08%	4,458,735
16	SYK	Stryker Corporation	1.94%	2,440,929
17	MDT	Medtronic plc	1.77%	9,085,707
18	MCK	McKesson Corporation	1.70%	868,089
19	ELV	Elevance Health, Inc.	1.59%	1,564,136
20	CI	The Cigna Group	1.37%	1,867,184
21	BSX	Boston Scientific Corporation	1.33%	10,510,264
22	REGN	Regeneron Pharmaceuticals, Inc.	1.15%	714,401
23	HCA	HCA Healthcare, Inc.	1.10%	1,109,387
24	COR	Cencora, Inc.	0.95%	1,378,649
25	EW	Edwards Lifesciences Corporation	0.91%	4,112,601

Showing 25 of 63 holdings

Subscribe to see the full list

Activate Now

As of May 28, 2026